Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, filed on Thursday with the SEC to raise up to $90 million in an initial public offering.
Valeritas’ IPO filing arrives just one week after insulin pump maker Asante Solutions (PUMP) postponed its proposed $49 million offering. Another insulin pump company, Tandem Diabetes Care (TNDM), has traded down about 45% from one year ago and -14% from three months ago.
Help employers find you! Check out all the jobs and post your resume.
